semaglutide and gout GLP-1 weight loss drug study finds small increase in risk of osteoporosis GLP-1 weight loss drugs could

And the gut microbiome produces neurotransmitters, short-chain fatty acids, and inflammatory mediators that directly influence brain function

When to Wean Down GLP-1 Medications If youve been on your GLP-1 journey for a while, you might be contemplating whether its time to transition to maintenance doses

Fatigue is one of the most frequently reported side effects for those starting GLP-1 medications

The patient required treatment and monitoring in an ICU to make a full recovery, they write

miRNAs are small, mature, non-coding RNA molecules (about 22 nucleotides long) that can affect the processing of target mRNAs at the post-transcriptional level by translational inhibition or promoting mRNA degradation (281)